Carlisle Companies Incorporated · CSL · FY2025 Q4 · Calendar Q1 2026

Carlisle Reaffirms Vision 2030, Citing Reroofing and Product Innovation

Carlisle’s stated outlook rests on durable commercial reroofing demand, higher product content, and execution on product development and operations. The case is supported by reaffirmed Vision 2030 ambitions and a constructive 2026 outlook, but depends on converting innovation and acquisitions into growth while managing construction softness and input-cost pressures.

Reported After market closeNYSEBasic Materials $14.54B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $3.90 Consensus $3.58
EPS surprise +8.9% Reported versus consensus
Reported revenue $1.13B Consensus $1.11B
Revenue surprise +1.7% Reported versus consensus

Market reaction

event-close to next-session close
Stock move +11.1% Event window
SPY move -0.5% Same window
Abnormal move +11.6% Stock minus SPY
Volume 4.5× Versus trailing sessions
Subsequent drift -5.2% Up to 20 sessions
CSLSPY benchmark

Ask FN2 about CSL FY2025 Q4

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Compared with the prior-quarter analysis, the FY2025 call moves the focus from a lowered full-year outlook and near-term channel disruption toward a maintained 2026 outlook, reaffirmed Vision 2030 targets, and planned margin expansion. Management also emphasized increased R&D, new products, and continued disciplined bolt-on acquisitions.

Guidance delta

Management maintained its outlook, with low-single-digit revenue growth and approximately 50 basis points of EBITDA margin expansion for 2026, as summarized in the call analysis. Vision 2030 goals of $40 adjusted EPS and greater than 25% ROIC were reaffirmed.

Key takeaways

  • Management described commercial reroofing as a resilient demand source amid softer new construction.
  • The 2026 outlook calls for low-single-digit revenue growth and approximately 50 basis points of EBITDA margin expansion.
  • Product launches, higher R&D investment, operational improvement, and bolt-on acquisitions are central to the stated growth plan.

Management priorities

  • Advance Vision 2030, including product innovation and an increase in R&D investment to 3% of sales.
  • Pursue operational excellence through the Carlisle Operating System, automation, and AI initiatives.
  • Continue disciplined building-envelope acquisitions and capital returns, including planned share repurchases and dividend growth.

Follow CSL with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
CSL EPS earnings history estimate and actual scatter chart 10 reported fiscal quarters and 4 future estimate-only quarters. Q2 '24 estimate $5.99 Q2 '24 actual $6.24, beat Q3 '24 estimate $5.82 Q3 '24 actual $5.78, miss Q2 '25 estimate $6.58 Q2 '25 actual $6.27, miss Q3 '25 estimate $5.47 Q3 '25 actual $5.61, beat Q4 '25 estimate $3.58 Q4 '25 actual $3.90, beat Q1 '26 estimate $3.33 Q1 '26 actual $3.63, beat Q2 '26 estimate $6.35 Q2 '26 actual $7.03, beat Q3 '26 estimate $5.89 Q3 '26 actual $5.92, beat Q4 '26 estimate $4.44 Q1 '27 estimate $4.23 Q2 '27 estimate $8.16 Q3 '27 estimate $6.86
Show 2 more >

Analyst Consensus ?

ConsensusBuy25 ratings
Bullish1664.0%
Neutral936.0%
Bearish00.0%

Analyst 52W Price Targets

$376.31Current
$355Low
$419.55Average
$480High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 2, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
Baird Outperform OutperformMaintainOct 13, 2026
Truist Securities Hold HoldMaintainJul 7, 2026
Oppenheimer Outperform OutperformMaintainApr 24, 2026
JP Morgan Overweight OverweightMaintainMar 9, 2026
Goldman Sachs Buy BuyMaintainOct 13, 2025
Loop Capital Hold BuyDowngradeJul 31, 2025
Zelman & Assoc Neutral UnderperformUpgradeApr 14, 2025
Jefferies Hold BuyDowngradeSep 26, 2023
BMO Capital Outperform OutperformMaintainMay 1, 2023
Credit Suisse Outperform OutperformMaintainApr 11, 2023
Zelman Buy BuyMaintainNov 15, 2021
Northcoast Research Buy NeutralUpgradeJun 30, 2021
Longbow Research Neutral BuyDowngradeApr 12, 2021
Berenberg Buy BuyMaintainJan 14, 2020
Buckingham Research Neutral BuyDowngradeJul 8, 2019
B. Riley Securities Buy BuyMaintainOct 24, 2018
B. Riley FBR Buy BuyMaintainOct 24, 2018
Buckingham Buy BuyMaintainSep 5, 2017
Topeka Buy BuyMaintainMay 26, 2016
Wunderlich Buy BuyMaintainDec 16, 2015
KeyBanc Equal Weight Sector WeightMaintainSep 29, 2015
RBC Capital Perform Sector PerformMaintainNov 25, 2014
FBR Capital Outperform Market PerformUpgradeApr 15, 2014
SunTrust Robinson Humphrey Buy NeutralUpgradeJul 24, 2013
Citigroup Neutral NeutralMaintainApr 25, 2013
Show less

Named analyst price targets

Upside is calculated against the persisted current price $376.31. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
Robert W. BairdAnalyst unavailable$410$345.55 +9.0%Oct 29, 2026
D.A. DavidsonGarik Shmois$355$321.74 -5.7%Oct 9, 2026
D.A. DavidsonAnalyst unavailable$410$362.52 +9.0%Aug 24, 2026
Robert W. BairdAnalyst unavailable$412$334.54 +9.5%Jul 30, 2026
Robert W. BairdAnalyst unavailable$405$345.39 +7.6%Jul 20, 2026
Raymond JamesSam Darkatsh$425$361.28 +12.9%Apr 27, 2026
Truist FinancialKeith Hughes$360$368.57 -4.3%Apr 24, 2026
OppenheimerAnalyst unavailable$425$363.7 +12.9%Apr 24, 2026
Robert W. BairdTimothy Wojs$425$363.7 +12.9%Apr 24, 2026
Robert W. BairdAnalyst unavailable$402$357.71 +6.8%Apr 15, 2026
Robert W. BairdAnalyst unavailable$420$355.84 +11.6%Feb 4, 2026
Truist FinancialKeith Hughes$340$330 -9.6%Oct 30, 2025
Robert W. BairdAnalyst unavailable$385$323.92 +2.3%Oct 13, 2025
Truist FinancialKeith Hughes$350$338.01 -7.0%Sep 22, 2025
Loop Capital MarketsAnalyst unavailable$395$410.57 +5.0%Jul 31, 2025
Truist FinancialKeith Hughes$390$373.01 +3.6%Apr 24, 2025
Robert W. BairdTimothy Wojs$506$480.93 +34.5%Oct 15, 2024
Loop Capital MarketsGarik Shmois$475$420.3 +26.2%Sep 18, 2024
OppenheimerBryan Blair$480$401.71 +27.6%Sep 4, 2024
Robert W. BairdTimothy Wojs$500$430.54 +32.9%Jul 15, 2024
Robert W. BairdTimothy Wojs$435$400.5 +15.6%Apr 9, 2024
Goldman SachsSusan Maklari$455$391.19 +20.9%Apr 3, 2024
Robert W. BairdTimothy Wojs$300$245.33 -20.3%Apr 18, 2022
Show less

Track every rating change on CSL the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Carlisle Companies Incorporated operates as a manufacturer and supplier of building envelope products and solutions in the United States, Europe, North America, and internationally. It operates through two segments, Carlisle Construction Materials (CCM) and Carlisle Weatherproofing Technologies (CWT). The CCM segment offers single-ply roofing solutions, including ethylene propylene diene monomer, thermoplastic polyolefin, polyvinyl chloride membrane, polyiso insulation, and engineered metal roofing and wall panel systems for commercial and residential buildings.…

Historical context

All CSL earnings

Basic Materials peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the CSL recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
  2. FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
  3. Polygon adjusted daily market bars · 2026-11-02T05:40:42.038981+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-11-02T05:40:42.035990+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-11-02. For educational purposes only; not investment advice.